Molecular Therapy: Nucleic Acids (Mar 2021)

miR-130a activates the VEGFR2/STAT3/HIF1α axis to potentiate the vasoregenerative capacity of endothelial colony-forming cells in hypoxia

  • Jasenka Guduric-Fuchs,
  • Edoardo Pedrini,
  • Judith Lechner,
  • Sarah E.J. Chambers,
  • Christina L. O’Neill,
  • Joana Mendes Lopes de Melo,
  • Varun Pathak,
  • Rachel H. Church,
  • Stuart McKeown,
  • James Bojdo,
  • Kiran J. Mcloughlin,
  • Alan W. Stitt,
  • Reinhold J. Medina

Journal volume & issue
Vol. 23
pp. 968 – 981

Abstract

Read online

Hypoxia modulates reparative angiogenesis, which is a tightly regulated pathophysiological process. MicroRNAs (miRNAs) are important regulators of gene expression in hypoxia and angiogenesis. However, we do not yet have a clear understanding of how hypoxia-induced miRNAs fine-tune vasoreparative processes. Here, we identify miR-130a as a mediator of the hypoxic response in human primary endothelial colony-forming cells (ECFCs), a well-characterized subtype of endothelial progenitors. Under hypoxic conditions of 1% O2, miR-130a gain-of-function enhances ECFC pro-angiogenic capacity in vitro and potentiates their vasoreparative properties in vivo. Mechanistically, miR-130a orchestrates upregulation of VEGFR2, activation of STAT3, and accumulation of HIF1α via translational inhibition of Ddx6. These findings unveil a new role for miR-130a in hypoxia, whereby it activates the VEGFR2/STAT3/HIF1α axis to enhance the vasoregenerative capacity of ECFCs.

Keywords